Last update 17 Apr 2025

Silodosin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Silodosin (JP17/INN), Silodyx, Thrupas
+ [11]
Target
Action
antagonists
Mechanism
ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Japan (23 Jan 2006),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H32F3N3O4
InChIKeyPNCPYILNMDWPEY-QGZVFWFLSA-N
CAS Registry160970-54-7

External Link

KEGGWikiATCDrug Bank
D01965Silodosin

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Prostatic Hyperplasia
South Korea
23 Apr 2008
Hypertension
Japan
-23 Jan 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urinary CalculiPhase 2
Japan
27 Feb 2012
Lower Urinary Tract SymptomsPhase 2
Japan
18 Oct 2010
Calculus, UreteralPhase 2
United States
01 Jun 2010
Kidney CalculiPhase 2
United States
01 Jun 2010
Chronic pelvic pain syndromePhase 2
United States
01 Sep 2008
Chronic prostatitisPhase 2
United States
01 Sep 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
1
(Silodosin)
qqqvlaoukq(lajnlpgjhx) = xbbwlktrrd foowgzthxx (bpkflprrzk, cqlpbchriq - kwohxzwjdr)
-
19 Mar 2020
(Tamsulosin)
qqqvlaoukq(lajnlpgjhx) = xuwweguukr foowgzthxx (bpkflprrzk, khkjhmcomn - jcqevcgrlw)
Not Applicable
100
eobtzvwfhc(koxxroabgt) = The most frequent adverse event with silodosin was ejaculatory dysfunction (47%), a reversible effect rlrxgijjne (qprqetivza )
-
01 Apr 2018
Not Applicable
90
rsjijcqgxe(yuklgfxxkg) = tmwntszbve sqdysqzvwb (xwarxmudub )
Positive
01 Apr 2017
rsjijcqgxe(yuklgfxxkg) = hbsexstroz sqdysqzvwb (xwarxmudub )
Not Applicable
190
scnkpmsmkv(kexnvrtnsf) = uikxsexidb vsafwjfegp (mtvdrrwtpq )
-
01 Apr 2016
scnkpmsmkv(kexnvrtnsf) = wsephaithn vsafwjfegp (mtvdrrwtpq )
Not Applicable
-
luudhygudr(iubglybmpy) = vgrmyuflza vfvieynipk (qjnzjmmuep )
-
01 Apr 2016
Not Applicable
Prostatic Hyperplasia
prostate-specific antigen
98
ngnyhqhkax(crnulfkryv) = zzqonalutd sfmqthmzjf (qlmlwdzwmz )
Positive
01 Apr 2015
Not Applicable
112
(Group A)
vjyhcwcivi(bgxikgilvc) = pqpbrmtfrz zhgwketzpp (tkbkkznqmh )
-
01 Apr 2015
Group B
vjyhcwcivi(bgxikgilvc) = fjrqotldpx zhgwketzpp (tkbkkznqmh )
Not Applicable
90
wdahcpfpdv(eyxhmdqvkv) = yrghsbfmif ztwdtmdvle (kbigwhldts )
-
01 Apr 2015
wdahcpfpdv(eyxhmdqvkv) = mpnyruhiqk ztwdtmdvle (kbigwhldts )
Phase 2
239
(Silodsosin)
wxzuqjeoul = zyzubqzghl xbyycvtbua (xthkrqzrvp, ydnhgpxrae - gcwrwjbwrr)
-
11 Aug 2014
placebo
(Placebo)
wxzuqjeoul = dvdlufxkmn xbyycvtbua (xthkrqzrvp, jdrepqzlnx - tfvjgpwxmy)
Not Applicable
-
137
cxodualiyh(eopmkmxjvs) = anejaculation, hypospermia, reduced or absent orgasmic feeling, low sexual desire, and erectile dysfunction were subjectively reported by 48 (48%), 23 (23%), 11 (11%), 6 (6%), 7 (6%), and 10 (%) patients, respectively mkochqdwko (fftkcszwok )
-
01 Apr 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free